ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

MedImpact Completes Acquisition of Sav-Rx

Transaction expands MedImpact’s scale, expertise, and health solutions portfolio while maintaining Sav-Rx’s mission and service model

MedImpact Healthcare Systems, Inc., the nation’s largest independent pharmacy benefit and health solutions company, today announced the completion of its acquisition of Sav-Rx, a pharmacy benefit manager with more than five decades of experience serving organized labor.

The transaction strengthens MedImpact’s ability to serve a broad range of clients by adding specialized expertise, scale, and deep insight into a key market segment. Sav-Rx will continue to operate independently, with no changes to its leadership or its long-standing service model.

Sav-Rx brings a proven, high-touch approach to pharmacy benefit management and a deep understanding of labor-sponsored plans. Combined with MedImpact’s national scale, clinical capabilities, and technology platform, the acquisition enhances MedImpact’s ability to deliver more comprehensive, flexible, and cost-effective solutions across its client base.

“This investment reflects our deep and longstanding commitment to organized labor,” said Frederick Howe, MedImpact’s Chairman and CEO. “Sav-Rx brings decades of labor-focused experience, and together we are building a broader health solutions platform with the scale, expertise, and flexibility to serve clients in even more meaningful ways.”

The acquisition also represents the next step in MedImpact’s ongoing transformation into a diversified health solutions company. Through targeted acquisitions and sustained investment, MedImpact is expanding its buying power, services, and domain expertise to support clients with greater choice, depth, and control.

As part of MedImpact, Sav-Rx gains access to additional resources that support continued investment and long-term growth, while maintaining the independence and client focus that have defined the organization since its founding in 1968.

“Our clients rely on us because we understand their needs and deliver tailored, high-touch service,” said Christy Piti, CEO of Sav-Rx. “That will not change. Being part of MedImpact allows us to strengthen what we do best, with added scale and support.”

MedImpact remains independent and privately held, free from ownership by insurers, pharmacy chains, or Wall Street investors. This structure enables the company to integrate specialized capabilities like Sav-Rx, while remaining focused on delivering innovation, flexibility, and value to clients and consumers.

About MedImpact

San Diego-based MedImpact Healthcare Systems, Inc. is the nation’s largest independent health solutions, technology, and pharmacy benefit management provider. For 35 years, MedImpact has helped commercial and government healthcare payers improve member health, manage benefits, and reduce drug costs. Today, MedImpact serves more than 20 million members and processes more than $40 billion in pharmacy transactions annually. To learn more, visit us online, follow us on LinkedIn, or contact us at info@MedImpact.com.

MedImpact Completes Acquisition of Sav-Rx

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  242.96
+3.66 (1.53%)
AAPL  270.01
+10.53 (4.06%)
AMD  246.27
+9.54 (4.03%)
BAC  54.03
+0.83 (1.56%)
GOOG  344.90
+6.37 (1.88%)
META  706.41
-10.09 (-1.41%)
MSFT  423.37
-6.92 (-1.61%)
NVDA  185.61
-5.52 (-2.89%)
ORCL  160.06
-4.52 (-2.75%)
TSLA  421.81
-8.60 (-2.00%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.